News and Updates

The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2 to 6 with type 1 diabetes (T1D). It is the first marketed device that can automatically adjust insulin delivery based on continuous glucose monitoring (CGM) values for children aged 2-6 years.

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which automatically monitors and regulates blood-sugar levels—is safe and effective in children as young as age six with type 1 diabetes (T1D): Tandem’s t:slim X2™ insulin pump with Control-IQ™ technology. The algorithm in the Control-IQ technology […]

On July 1, Breakthrough T1D Play launched Game Over, T1D, a livestream fundraiser that will continue through 2021. Thanks to a big fundraising push August 7­–16, Game Over, T1D surpassed its initial $50,000 event goal and has already raised almost $64,000.

Social distancing is key in preventing the spread of COVID, but what happens when school starts? Members of the Type 1 Diabetes Community from Spanish-speaking families share their perspectives.

Breakthrough T1D to benefit from virtual live premiere of new movie produced by David Henrie and Selena Gomez.

While genetics play a major role in the development of type 1 diabetes (T1D), mounting evidence supports the strong influence of the intestinal environment—called the microbiome—in this disease. Nevertheless, few “microbiome-based” strategies have been tested in clinical trials. Recently, Graciela Lorca, Ph.D., professor of microbiology at the University of Florida, found that one bacterial strain—a […]

You’re going to hear about a part of your body that, really, goes unnoticed in type 1 diabetes (T1D): blood vessels. But blood vessels are everywhere. From your eye to your lungs to even your pancreas. And they’re really, really important. Do you know that these vessels transport blood cells, nutrients and oxygen to all […]

International Society of Chief Data Officers (isCDO) recognizes Breakthrough T1D’s Sri Mishra for “Transformation of Collaboration from Inwards to Outwards.”

Type 1 diabetes (T1D) can be hard to predict in high risk children. Testing for the presence of T1D autoantibodies—antibodies against one’s own proteins—helps reduce the incidence of diabetic ketoacidosis (DKA)—a common occurrence in children upon diagnosis, that can lead to death if not treated—but this testing is not widely available. While having 2 or […]

Beta cell replacement therapies for type 1 diabetes (T1D) have made significant advances in just the past 10 years. We now have insulin-producing beta cells, derived from stem cells, which makes a donor (needed to provide the beta cells) obsolete. We have seen that stem cell-derived precursors can—once implanted in humans—mature into beta cells and […]